BioInfra Life Science Inc.

A266470

KR7266470004

Biotechnology & Medical Research

End-of-day quote Korea S.E. Other stock markets 18:00:00 2024-05-30 EDT			5-day change	1st Jan Change
269 ^KRW	-14.60%		-5.28%	-26.30%

2021	BioInfra Life Science Inc. announced that it has received KRW 4.4999845 billion in funding from SBI Investment KOREA Co., Ltd., DSC Investment Inc., Skywalk Asset Management Co., Ltd.	CI
2021	BioInfra Life Science Inc. announced that it has received KRW 1.999998 billion in funding from Korea Investment Partners Co. Ltd., Skywalk Asset Management Co., Ltd.	CI

BIOINFRA Life Science Inc. announced that it has received KRW 4 billion in funding from Hizeasset Investment Co., Ltd

December 17, 2019

On December 18, 2019, BIOINFRA Life Science Inc. closed the transaction.

Latest news about BioInfra Life Science Inc.

BioInfra Life Science Inc. announced that it has received KRW 4.4999845 billion in funding from SBI Investment KOREA Co., Ltd., DSC Investment Inc., Skywalk Asset Management Co., Ltd.	21-06-22	CI
BioInfra Life Science Inc. announced that it has received KRW 1.999998 billion in funding from Korea Investment Partners Co. Ltd., Skywalk Asset Management Co., Ltd.	21-06-15	CI
BioInfra Life Science Inc. announced that it expects to receive KRW 4.4999845 billion in funding from SBI Investment KOREA Co., Ltd., DSC Investment Inc., Skywalk Asset Management Co., Ltd.	21-06-14	CI
BioInfra Life Science Inc. announced that it expects to receive KRW 2.999986 billion in funding from Korea Investment Partners Co. Ltd., Skywalk Asset Management Co., Ltd.	21-05-16	CI
BIOINFRA Life Science Inc. announced that it has received KRW 4 billion in funding from Hizeasset Investment Co., Ltd	19-12-17	CI
BIOINFRA Life Science Inc. announced that it expects to receive KRW 4 billion in funding from Hizeasset Investment Co., Ltd	19-12-12	CI
BIOINFRA Life Science Inc. announced that it has received KRW 5.9999922 billion in funding from Korea Investment Partners Co. Ltd., Lion Asset Management Co., Ltd., Root N Global Investors Co., Ltd.	19-07-15	CI
BIOINFRA Life Science Inc. announced that it expects to receive KRW 5.9999922 billion in funding from Korea Investment Partners Co. Ltd., Lion Asset Management Co., Ltd., Root N Global Investors Co., Ltd.	19-06-30	CI
BIOINFRA Inc. announced that it expects to receive KRW 1.5999938 billion in funding	18-09-26	CI

Chart BioInfra Life Science Inc.

Duration

Period

More charts

BioInfra Life Science Inc is a Korea-based company mainly engaged in the research and development and manufacture of protein chip contents. The Company provides diagnostic testing services and research services. The Company provides services such as multi-biomarker blood tests, diagnosis kit development, biomarker discovery, and peptide chip development.

Sector

Biotechnology & Medical Research

More about the company

Sector Other Biotechnology & Medical Research

	1st Jan change	Capi.
BIOINFRA LIFE SCIENCE INC.	-26.30%	2.74M
MODERNA, INC.	+43.36%	54.63B
IQVIA HOLDINGS INC.	-5.31%	39.92B
LONZA GROUP AG	+37.52%	38.82B
ICON PUBLIC LIMITED COMPANY	+14.75%	26.86B
CELLTRION, INC.	-12.56%	26.22B
ALNYLAM PHARMACEUTICALS, INC.	-22.45%	18.78B
UNITED THERAPEUTICS CORPORATION	+25.12%	12.21B
BIO-TECHNE CORPORATION	+0.04%	12.16B
MEDPACE HOLDINGS, INC.	+26.04%	11.94B

Other Biotechnology & Medical Research

BioInfra Life Science Inc.

Equities

A266470

KR7266470004

Biotechnology & Medical Research

BIOINFRA Life Science Inc. announced that it has received KRW 4 billion in funding from Hizeasset Investment Co., Ltd

Latest news about BioInfra Life Science Inc.

Chart BioInfra Life Science Inc.

Company Profile

Sector Other Biotechnology & Medical Research